Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
82.15
+4.46 (5.74%)
At close: Mar 6, 2026

SHA:688266 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-2,1542,110797.051,137
Trading Asset Securities
-40.5137.02248.9365.26
Cash & Short-Term Investments
2,0862,1942,2471,0461,202
Cash Growth
-4.91%-2.34%114.79%-12.97%-24.86%
Accounts Receivable
-143.63101.1488.9962.37
Other Receivables
-9.3810.8912.5112.45
Receivables
-153.01112.03101.574.82
Inventory
-182.86110.8598.9851.91
Other Current Assets
-45.8550.7945.377.33
Total Current Assets
-2,5762,5201,2921,406
Property, Plant & Equipment
-363.43271.21247.09188.91
Long-Term Investments
--5.991010
Other Intangible Assets
-50.0169.2791.03116.29
Long-Term Deferred Charges
-11.3916.3920.9613.03
Other Long-Term Assets
-3.884.027.4811.78
Total Assets
-3,0052,8871,6681,746
Accounts Payable
-197.1137.73151.72118.19
Accrued Expenses
-86.2282.0267.548.22
Short-Term Debt
-951.86795.16390.79131.81
Current Portion of Long-Term Debt
-4.9750.5650.0430.03
Current Portion of Leases
-11.213.1713.6913.55
Current Income Taxes Payable
-20.9520.6420.2918.58
Current Unearned Revenue
---0.280.36
Other Current Liabilities
-101.1535.8934.8820.16
Total Current Liabilities
-1,3731,135729.19380.89
Long-Term Debt
-44.35-50.09-
Long-Term Leases
-26.8629.4643.1848.18
Long-Term Unearned Revenue
-9.211.5545.0448.05
Long-Term Deferred Tax Liabilities
-5.79.5813.3215.77
Other Long-Term Liabilities
-292.4556.6--
Total Liabilities
-1,7521,242880.82492.88
Common Stock
-264.71264.71240240
Additional Paid-In Capital
-3,1203,3532,2222,205
Retained Earnings
--2,117-1,979-1,700-1,243
Comprehensive Income & Other
--14.47-5.95-2.84-6.32
Total Common Equity
1,1491,2541,633759.121,196
Minority Interest
--1.2611.9828.3756.76
Shareholders' Equity
1,1491,2531,645787.491,253
Total Liabilities & Equity
-3,0052,8871,6681,746
Total Debt
1,1261,039888.35547.8223.57
Net Cash (Debt)
960.791,1551,358498.18978.32
Net Cash Growth
-16.81%-14.97%172.65%-49.08%-36.78%
Net Cash Per Share
3.654.365.312.084.08
Filing Date Shares Outstanding
264.71264.71264.71264.49240
Total Common Shares Outstanding
264.71264.71264.71240240
Working Capital
-1,2021,385562.571,025
Book Value Per Share
4.344.746.173.164.98
Tangible Book Value
1,1141,2041,564668.091,080
Tangible Book Value Per Share
4.214.555.912.784.50
Buildings
-135.2641.9341.9341.21
Machinery
-145.53120.48121.7496.02
Construction In Progress
-123.47135.8386.6727.25
Source: S&P Global Market Intelligence. Standard template. Financial Sources.